Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The mainstay of treatment for atrial fibrillation remains pharmacological;however,catheter
ablation has increasingly been used over the last decades. The relative merits of each
strategy have not been extensively studied. Our study was designed to determine if catheter
ablation is a feasible option as first-line therapy for treating patients with symptomatic
AF.
Phase:
Phase 4
Details
Lead Sponsor:
Wuhan University
Collaborators:
Capital Medical University Dalian Medical University Guangdong General Hospital Guangdong Provincial People's Hospital Nanjing Medical University Peking Union Medical College Shanghai Chest Hospital West China Hospital